Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study.
Jingru YuErle RefsumPaulina WieszczyLise M HelsingenVera PerrinAmanda HögdénMagnus LøbergJohannes BlomMichael BretthauerHans-Olov AdamiWeimin YeMette KalagerPublished in: BMJ open gastroenterology (2023)
Patients with IBD have a statistically significant increased risk of malignant lymphomas compared with the general population, but the absolute risk remains low.